share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Atkinson Edward Morrow III

SEC announcement ·  Jun 13 16:15
Summary by Moomoo AI
Edward Morrow III, EVP and Chief Technical Operations Officer at Vertex Pharmaceuticals Inc. (VRTX), completed the sale of 14,112 shares of common stock over two consecutive days. On June 11, 2024, Morrow disposed of 6,824 shares at a price of $481.96 per share, followed by the sale of 7,288 shares on June 12, 2024, at $478.00 per share. The transactions resulted in a total market value of $6,772,559.04. Following these sales, Morrow directly holds 15,972 shares of Vertex Pharmaceuticals.
Edward Morrow III, EVP and Chief Technical Operations Officer at Vertex Pharmaceuticals Inc. (VRTX), completed the sale of 14,112 shares of common stock over two consecutive days. On June 11, 2024, Morrow disposed of 6,824 shares at a price of $481.96 per share, followed by the sale of 7,288 shares on June 12, 2024, at $478.00 per share. The transactions resulted in a total market value of $6,772,559.04. Following these sales, Morrow directly holds 15,972 shares of Vertex Pharmaceuticals.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more